FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL
Product details
Registration number: SIN16419P
Classification: Prescription Only
Active ingredients: FOSAPREPITANT DIMEGLUMINE 245.3MG EQV FOSAPREPITANT
Strength: 150MG/VIAL
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: APEX PHARMA MARKETING PTE. LTD.
ATC code: A04AD12
HSA approval date: 24 January 2022
Manufacturer(s): QILU PHARMACEUTICAL (HAINAN) CO., LTD.
Manufacturing country/countries: CHINA
What are the HSA registration number and classification for FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16419P
Classification: Prescription Only
What active ingredients and strength are recorded for FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: FOSAPREPITANT DIMEGLUMINE 245.3MG EQV FOSAPREPITANT
Strength: 150MG/VIAL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: APEX PHARMA MARKETING PTE. LTD.
Which manufacturers and countries are listed for FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): QILU PHARMACEUTICAL (HAINAN) CO., LTD.
Manufacturing country/countries: CHINA
Where can I look up FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16419P or the exact product name FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL. The general register link does not preselect this product.
What are the source dates for this FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this FOSAPREPITANT-AFT POWDER FOR INJECTION 150MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16419P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)